Oncology & Cancer

Researchers target mutation that leads to pancreatic cancer

After 30 years of discouraging results in attempting to develop drugs to inhibit a mutated protein associated with some of the more challenging cancers to treat, research on RAS proteins is booming.

page 14 from 40